Differential down-modulation of HLA class i and II molecule expression on human tumor cell lines upon in vivo transfer

Cancer Immunology, Immunotherapy

Volumn 60, Issue 11, 2011, Pages 1639-1645

  Turrini, Riccardo ^a   Merlo, Anna ^a   Dolcetti, Riccardo ^b   Zanovello, Paola ^a,c   Rosato, Antonio ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Down modulation; HLA I; HLA II; Mouse model

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; TRICHOSTATIN A;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGENIC MODULATION; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL TRANSFER; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT RESPONSE; TUMOR CELL LINE;

ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; EPIGENOMICS; FEMALE; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASMS; T-LYMPHOCYTES;

EID: 82355169695     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1086-3     Document Type: Article

References (17)

1. Merlo A, Turrini R, Bobisse S et al (2010) Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors. J Immunol. doi: 10.4049/jimmunol.0902850
2. KL Wright JP Ting 2006 Epigenetic regulation of MHC-II and CIITA genes Trends Immunol 27 405 412 10.1016/j.it.2006.07.007 16870508 10.1016/j.it.2006. 07.007 1:CAS:528:DC%2BD28XotlKhtrY%3D (Pubitemid 44216195)
3. L Paco AM Garcia-Lora C Casares, et al. 2007 Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response Int J Cancer 121 2023 2030 10.1002/ijc.22925 17621628 10.1002/ijc.22925 1:CAS:528:DC%2BD2sXhtFSjsLzM (Pubitemid 47463166)
4. C Garrido I Algarra I Maleno, et al. 2010 Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity Cancer Immunol Immunother 59 13 26 10.1007/s00262-009-0716-5 19430787 10.1007/s00262-009-0716-5 1:CAS:528:DC%2BD1MXht1OnsL%2FN
5. R Tao EF de Zoeten E Özkaynak, et al. 2007 Deacetylase inhibition promotes the generation and function of regulatory T cells Nat Med 13 1299 1307 10.1038/nm1652 17922010 10.1038/nm1652 1:CAS:528:DC%2BD2sXht1Kmtr3E (Pubitemid 350073591)
6. D Neureiter S Zopf T Leu, et al. 2007 Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models Scand J Gastroenterol 42 103 116 10.1080/00365520600874198 17190770 10.1080/00365520600874198 1:CAS:528:DC%2BD2sXhvVanurk%3D (Pubitemid 46033053)
7. XN Li Q Shu JMF Su L Perlaky SM Blaney CC Lau 2005 Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC Mol Cancer Ther 4 1912 10.1158/1535-7163.MCT-05-0184 16373706 10.1158/1535-7163.MCT-05-0184 1:CAS:528:DC%2BD2MXhtlCnsrvJ (Pubitemid 43056974)
8. B Seliger MJ Maeurer S Ferrone 2000 Antigen-processing machinery breakdown and tumor growth Immunol Today 21 455 464 10953098 10.1016/S0167-5699(00)01692-3 1:CAS:528:DC%2BD3cXmtVCmsr0%3D
9. B Seliger U Wollscheid F Momburg T Blankenstein C Huber 2001 Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells Cancer Res 61 1095 1099 10.1016/S0167-5699(00)01692-3 11221838 1:CAS:528:DC%2BD3MXhsFSqsrY%3D (Pubitemid 32174430)
10. A Merlo R Turrini R Dolcetti, et al. 2010 The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders Haematologica 95 1769 1777 10.3324/haematol.2010.023689 20421267 10.3324/haematol.2010.023689
11. S Bobisse M Rondina A Merlo, et al. 2009 Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors Cancer Res 69 9385 9394 10.1158/0008-5472.CAN-09-0494 19996290 10.1158/0008-5472.CAN-09-0494 1:CAS:528:DC%2BD1MXhsFGrtbnL
12. M de Jong T Maina 2010 Of mice and humans: are they the same? Implications in cancer translational research J Nucl Med 51 501 504 10.2967/jnumed.109.065706 20237033 10.2967/jnumed.109.065706
13. RJ Wall M Shani 2008 Are animal models as good as we think? Theriogenology 69 2 9 10.1016/j.theriogenology.2007.09.030 17988725 10.1016/j.theriogenology.2007.09.030 1:STN:280:DC%2BD2sjitVSqtA%3D%3D (Pubitemid 350166509)
14. TD Tlsty LM Coussens 2006 Tumor stroma and regulation of cancer development Annu Rev Pathol 1 119 150 10.1146/annurev.pathol.1.110304.100224 18039110 10.1146/annurev.pathol.1.110304.100224 1:CAS:528:DC%2BD28XktVOitb0%3D
15. G Mouillot C Marcou I Zidi, et al. 2007 Hypoxia modulates HLA-G gene expression in tumor cells Hum Immunol 68 277 285 10.1016/j.humimm.2006.10.016 17400064 10.1016/j.humimm.2006.10.016 1:CAS:528:DC%2BD2sXjslShsrg%3D (Pubitemid 46509544)
16. L Luo J Lu L Wei, et al. 2010 The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation BMC Cell Biol 11 91 10.1186/1471-2121-11-91 21092233 10.1186/1471-2121-11-91
17. CF Eisenberger R Viebahn W Lauchart H de Groot HD Becker 1994 MHC antigen presentation on the surface of hepatocytes: modulation during and after hypoxic stress Transpl Int 7 1 S163 S166 11271194 10.1111/j.1432-2277.1994.tb01338.x